1. Los-Arcos I, et al. Risk of infection associated with new therapies for the treatment of lymphoproliferative syndromes. Medicina Clínica (English Edition). 2020. doi: 10.1016/j.medcle.2019.07.006.
2. Swerdlow SH, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569.
3. Armitage JO, et al. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998 Aug;16(8):2780-95.
4. Harris NL, Jaffe et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. Ann Oncol. 1999 Dec;10(12):1419-32.